You are surely wondering if this can be true, right ?

Presently, In China is being sold the genetic test that predicts the future of newborns. Chinese parents can now decode the genome of their healthy babies, revealing their health risks. As much as they are likely to develop certain somatic or character traits. For many, there is a danger on relying on such data.

A boston based DNA sequencing company, decided to offers China the decoding of the complete genome of newborns, prompting questions about how parents should know about the genes of their children at birth. Veritas Genetics can provide information on 950 possible medical risks, 200 drug-related genes, and more than 100 probable physical traits in the baby. The service, called myBabyGenome, will cost $ 1,500, and according to some doctors, this might be unsecure, unsure and premature . One said "I think it is premature to handle a data set from unverified value on a vulnerable population such as babies," says Jim Evans, a professor of genetics at the University of North Carolina at Chapel Hill.

Evans particularly criticizes the predictions on the child's character, as the link between genetics and psychology is unclear. Veritas, born of the Personal Genome Project, specializes in economic sequencing of the complete genome. Since last year, it has offered US-grown individuals, under medical prescription, DNA analysis for $ 999.

Knowledge of your DNA may be decisive when confronted with a disease without diagnosis or a risk of cancer, but for the most part it is nothing more than a curious novelty. The demand from the public remains low. Veritas seems convinced that parents of Chinese babies can be more successful.

Mirza Cifric, Veritas CEO, has no product launch forecasts in the US where the medical class opposed the idea of ??sequencing for healthy children whose data would not have immediate medical applications.

Robert Green, a professor at Harvard University, co-heads a federally funded study called BabySeq, which analyzes the risks and benefits of the baby's genetic study, said in October that less than 10 percent of the 2,400 couples offered were Interested in the complete sequencing of the baby's newborn genome. The Veritas test, which covers 950 risks of disease, is a list of GreenScan's GreenScan project.